162 related articles for article (PubMed ID: 8483427)
21. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.
Barentsen R; van de Weijer PH; Schram JH
Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):73-80. PubMed ID: 9031963
[TBL] [Abstract][Full Text] [Related]
22. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
23. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
Buckler H; Al-Azzawi F;
BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
[TBL] [Abstract][Full Text] [Related]
24. Estradiol-releasing vaginal ring delivery system for urogenital atrophy. Experience over the past decade.
Bachmann G
J Reprod Med; 1998 Nov; 43(11):991-8. PubMed ID: 9839269
[TBL] [Abstract][Full Text] [Related]
25. Current overview of the management of urogenital atrophy in women with breast cancer.
Pruthi S; Simon JA; Early AP
Breast J; 2011; 17(4):403-8. PubMed ID: 21645165
[TBL] [Abstract][Full Text] [Related]
26. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms.
Speroff L
Obstet Gynecol; 2003 Oct; 102(4):823-34. PubMed ID: 14551014
[TBL] [Abstract][Full Text] [Related]
28. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.
Eriksen B
Am J Obstet Gynecol; 1999 May; 180(5):1072-9. PubMed ID: 10329858
[TBL] [Abstract][Full Text] [Related]
29. Urogenital atrophy and low-dose vaginal estrogen therapy.
Notelovitz M
Menopause; 2000; 7(3):140-2. PubMed ID: 10810957
[No Abstract] [Full Text] [Related]
30. Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets.
Mettler L; Olsen PG
Maturitas; 1991 Dec; 14(1):23-31. PubMed ID: 1791769
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of vaginal use of topical estriol in postmenopausal women with urogenital atrophy.
Chuery AC; Speck NM; de Moura KF; Belfort PN; Sakano C; Ribalta JC
Clin Exp Obstet Gynecol; 2011; 38(2):143-5. PubMed ID: 21793275
[TBL] [Abstract][Full Text] [Related]
32. Urogenital atrophy.
Calleja-Agius J; Brincat MP
Climacteric; 2009 Aug; 12(4):279-85. PubMed ID: 19387880
[TBL] [Abstract][Full Text] [Related]
33. The urogenital system and the menopause.
Calleja-Agius J; Brincat MP
Climacteric; 2015; 18 Suppl 1():18-22. PubMed ID: 26366796
[TBL] [Abstract][Full Text] [Related]
34. The estradiol vaginal ring--a study of existing clinical data.
Bachmann G
Maturitas; 1995 Dec; 22 Suppl():S21-9. PubMed ID: 8775773
[TBL] [Abstract][Full Text] [Related]
35. Complication of a 2-mg estradiol vaginal ring: fibrotic vaginal adhesion.
Pratts ME; Shen W
Menopause; 2014 Nov; 21(11):1254-6. PubMed ID: 24937026
[TBL] [Abstract][Full Text] [Related]
36. Preoperative treatment with oestradiol in women scheduled for vaginal operation for genital prolapse. A randomised, double-blind trial.
Felding C; Mikkelsen AL; Clausen HV; Loft A; Larsen LG
Maturitas; 1992 Dec; 15(3):241-9. PubMed ID: 1465038
[TBL] [Abstract][Full Text] [Related]
37. The clinical platform for the 17beta-estradiol vaginal releasing ring.
Bachmann GA
Am J Obstet Gynecol; 1998 May; 178(5):S257-60. PubMed ID: 9609602
[TBL] [Abstract][Full Text] [Related]
38. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy.
Morali G; Polatti F; Metelitsa EN; Mascarucci P; Magnani P; Marrè GB
Arzneimittelforschung; 2006; 56(3):230-8. PubMed ID: 16618016
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
[TBL] [Abstract][Full Text] [Related]
40. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
Crandall C
J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
